Commercialization, Forecasts

Novartis, AbbVie dominate the top 10 list of blockbusters prepping for a 2019 marketing launch

Every company on this list of the top 10 2019 marketing launches — compiled by Evaluate in January — has a lot to prove.

We have Alexion, trying to safeguard its big moneymaking franchise, topping the chart.

Novartis and its new CEO are the dominant player this year, with 3 top contenders for blockbuster status — a big opportunity for the crew running the Basel-based pharma giant.

In order to read this article, you must be an Endpoints News subscriber. (It's free to subscribe.)

← Go back

We produce two daily email newsletters designed to give you a complete picture of what's important in biopharma. It's free to subscribe and never any spam. Join 47,900+ biopharma executives who read Endpoints News every day.

Access is subject to the terms in our Privacy Policy.

The best place to read Endpoints News? In your inbox.

Comprehensive daily news report for those who discover, develop, and market drugs. Join 47,900+ biopharma pros who read Endpoints News by email every day.

Free Subscription

Research Scientist - Immunology
Recursion Pharmaceuticals Salt Lake City, UT
Director of Operations
Atlas Venture Cambridge, MA

Visit Endpoints Careers ->